Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical <i>SMN1</i> and <i>SMN2</i> Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing.

Human mutation·2025
Same author

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.

Leukemia·2022
Same author

Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion.

Viruses·2021
Same author

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results.

Leukemia·2021
Same author

Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative.

JCO precision oncology·2021
Same author

Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.

Leukemia·2021

Related Experiment Video

Updated: Jun 22, 2026

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Technical standards and guidelines for myotonic dystrophy type 1 testing.

Thomas W Prior1,

  • 1Department of Pathology, Ohio State University, Columbus, Ohio 43210, USA. thomas.prior@osumc.edu

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|June 24, 2009
PubMed
Summary
This summary is machine-generated.

Myotonic dystrophy type 1 is caused by a CTG expansion in a specific gene. Genetic testing using Southern transfer and PCR accurately identifies affected individuals, correlating expansion size with disease severity.

More Related Videos

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Related Experiment Videos

Last Updated: Jun 22, 2026

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
14:10

Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies

Published on: January 31, 2013

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
09:44

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients

Published on: April 12, 2011

Area of Science:

  • Genetics
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Myotonic dystrophy type 1 (DM1) is an autosomal dominant genetic disorder affecting multiple body systems.
  • DM1 results from an unstable CTG nucleotide repeat expansion in the 3'-untranslated region of the myotonic dystrophy protein kinase (DMPK) gene.
  • The clinical presentation and age of onset in DM1 patients correlate with the size of the CTG repeat expansion.

Purpose of the Study:

  • To provide a checklist for genetic testing professionals involved in diagnosing Myotonic dystrophy type 1.
  • To outline accurate methods for identifying patients with DM1 based on genetic testing.
  • To standardize the genetic analysis of DM1 according to established clinical genetics laboratory guidelines.

Main Methods:

  • Utilizing Southern transfer techniques for genetic analysis.
  • Employing polymerase chain reaction (PCR) for precise CTG repeat size determination.
  • Combining Southern transfer and PCR for accurate Myotonic dystrophy type 1 diagnosis.

Main Results:

  • The combined Southern transfer and PCR method accurately identifies individuals with Myotonic dystrophy type 1.
  • The size of the CTG expansion is a key factor influencing disease onset and severity.
  • This diagnostic approach provides reliable results for clinical genetic testing.

Conclusions:

  • Southern transfer and PCR are effective methods for diagnosing Myotonic dystrophy type 1.
  • Accurate genetic testing is crucial for understanding disease progression and patient management.
  • The developed checklist aids genetic testing professionals in standardizing DM1 analysis.